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osting by EAbstract Background: The C3 component of complement tends to be reduced in cirrhosis and
patients with reduced ascitic fluid C3 concentration and reduced opsonic activities have been shown
to be predisposed to SBP [1].
Aim of the work: To compare the level of ascitic fluid C3 concentration in cirrhotic patients with
and without spontaneous bacterial peritonitis to determine its possible protective role against
acquiring infection.
Methods: This is a prospective case-control study in which we recruited 45 cirrhotic patients pre-
senting with ascites, of which 25 showed evidence of SBP. All patients had diagnostic paracentesis,
received the appropriate treatment, discharged and followed-up monthly for 3 months, with ascitic
fluid C3 measurement. Ascitic fluid C3 was compared between both groups at baseline and for three
successive reading over 3 months. It was also compared in the same patients group over this interval
and correlated with other AF parameters at baseline reading.
Conclusion: Ascitic fluid C3 is reduced in cirrhotic patients with SBP and stays lower compared
with those without the infection after the first episode. So we conclude that C3 plays an important
role in the local defense of ascitic fluid and needs further long term follow-up studies to evaluate its
role as a predictor of prognosis for cirrhotic ascitic patients.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.2594291.
oo.com (A.T. Kamal).
y. Production and hosting by
Shams University.
lsevier1. Introduction
Ascites is the most common complication in patients with
decompensated cirrhosis. Approximately 50% of patients with
compensated cirrhosis will develop ascites over a 10-year
period [2]. Patients with cirrhosis and ascites show higher
susceptibility to bacterial infections mainly because of the
inadequate defense mechanisms. The most frequent and most
severe one being spontaneous bacterial peritonitis (SBP).
Prevalence of Spontaneous bacterial peritonitis in cirrhotic
patients with ascites is as high as 18%, with 40–70% associated
mortality [3]. Spontaneous bacterial peritonitis is probably
related to several impaired defense mechanisms, such as
depressed reticuloendothelial system phagocytic activity,
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bactericidal activity of ascitic fluid [4]. Ascitic fluid comple-
ment 3 (C3) concentration and opsonic activities are important
protective factors against SBP. The C3 component of comple-
ment tends to be reduced in cirrhosis and patients with reduced
ascitic fluid C3 concentration and reduced opsonic activities
have been shown to be predisposed to SBP [1].
This study was designed with the aim to compare the level
of ascitic fluid C3 concentration in cirrhotic patients with and
without spontaneous bacterial peritonitis (SBP) monthly over
a period of 3 months, to determine its possible protective role
against this infection.
2. Patients and methods
This is a prospective case-control study, conducted in the inter-
nal medical department and the outpatient clinics of Ain
Shams University Hospitals, from October 2009 till October
2010. A total of 45 patients were recruited for the study; 25 cir-
rhotic patients admitted with the diagnosis of spontaneous
bacterial peritonitis (group I) and 20 patients with the diagno-
sis of cirrhotic ascites without evidence of peritonitis as con-
trols (group II). The diagnosis of SBP was based on the
presence of ascitic fluid (AF) polymorphonuclear (PMN) cell
count of 250 cells/ml or more, in the absence of secondary peri-
tonitis, with or without positive ascitic fluid culture.
2.1. Exclusion criteria
Patients who had received antibiotics or diuretics up to one
week prior to admission were excluded. Other exclusion crite-
ria were hepatocellular carcinoma, portal vein thrombosis,
hepatorenal syndrome and diabetes mellitus. We ruled out pa-
tients with the history of recent antibiotic use, to ensure
matched groups of patients and controls. The rest of exclusion
criteria were mainly concerned with their potential effect on
protein synthesis and loss.
At enrollment, complete physical examination was done
including signs of decompensated liver cirrhosis mainly the
presence of ascites. Basic laboratory work up including: liver
function test, renal function test, fasting and postprandial
blood glucose, complete blood count, prothrombin concentra-
tion and INR were performed for all patients. In addition, test-
ing for the presence of hepatitis B surface antigen (HBs Ag),
hepatitis B core antibody (HBc Ab) and hepatitis C virus anti-
body (HCV Ab) was done for all patients.
Diagnostic paracentesis was performed for all patients on
admission under strict aseptic conditions under ultrasono-
graphic guidance. The ascetic fluid (AF) obtained was tested
for: glucose, total proteins, albumin, LDH and polymorpho-
nuclear leukocytic count (PMNLs). Ascitic fluid cultures were
performed by inoculating 10 ml of the fluid in aerobic and
anaerobic blood culture bottles at bedside and incubated
for 48 h at 37 C. Complement 3 (C3) determinations in
AF were measured by nephelometry (Beckman ARRAY
Beckman instrument Co., California) using anti-C3
antiserum.
Patients in both groups were given the appropriate
treatment during their hospital stay. Patients with SBP were
given antibiotics immediately after taking ascitic fluid samples.
A combination of third generation cephalosporin andmetronidazol intravenously was the standard treatment. Aver-
age hospital stay was 7–10 days.
Discharged patients in both groups were followed-up
monthly for three successive months for repeat clinical exami-
nation in the outpatient clinics. Ascitic fluid samples were col-
lected each visit for the re-measurement of C3 level.
By the end of the study, the total number of patients com-
pleting three successive follow-up visits in the outpatient clinic
was 15 in each group. Drop out was either due to death or fail-
ure to show up for the repeat examinations.
This study was approved by the local ethics committee of
the Ain Shams University, and an informed written consent
was obtained from all patients before enrollment in this study.
2.2. Statistical analysis
The statistical analysis was performed using the SPSS (Statis-
tical Program for Social Sciences), version 13. Data are ex-
pressed as means ± SD. Comparisons between groups were
performed using the Student’s t-test for quantitative variables
and Chi square for qualitative variables. Comparison of ascitic
fluid C3 levels across the study period was performed for each
group separately using repeated measures ANOVA. Compari-
son between the various pairwise combinations of baseline and
follow-up readings of ascitic fluid C3 levels was performed
using the paired t-test for each group separately. Correlations
were performed using the Pearson’s correlation coefficient. A
P-value of less than 0.05 was considered significant.
3. Results
Demographic criteria: Group I included 11 males (73.33%) and
four females (26.67%) while group II included 10 males
(66.67%) and five females (33.33%). Ages ranged from 44 to
58 with a mean of 51 ± 4.66 years in group I and from 41 to
57 with a mean of 50.4 ± 4.306 years in group II. There was
no statistically significant difference as regards both age and
sex distribution between both the study groups (P = 0.717
and 0.69, respectively).
Child-Pugh class: Four patients were Child-Pugh class B
(26.67%) and 11 patients were Child-Pugh class C (73.33%)
in group I, while 10 patients were Child-Pugh class B
(66.67%) and five patients were Child-Pugh C (33.33%) in
group II. There was a statistically significant difference be-
tween both groups as patients of group I showed more ad-
vanced Child-Pugh class (P = 0.028).
Etiology of liver cirrhosis: Group I included nine HCV po-
sitive (60%), four HBV positive (26.66%) and two combined
HCV and HBV positive (13.33%) patients. Group II included
12 HCV positive (80%), three HBV positive (20%) patients.
There was no statistically significant difference as regards etiol-
ogy of cirrhosis between both groups (P = 0.276).
Ascitic fluid culture: Ascitic fluid cultures were positive in 10
patients (66.67%) (classic SBP) and negative in five patients
(33.33%), i.e. culture negative neutrocytic ascites (CNNA) in
group I. Ascitic fluid cultures were negative in all patients of
group II. Among the 10 positive cultures, eight (i.e. 80%) were
caused by Gram-negative enterobacteriaceae (five Escherichia
coli and three Klebsiella pneumoniae) and two (i.e. 20%) were
caused by Gram-positive cocci (one Staphylococcus aureus and
one Streptococcus pneumoniae).
Table 1 Comparison between groups I and II as regards total leukocytic count, liver functions and renal functions.
Variable Group Range Mean ± SD T-test
t P
TLC (cell · 103 ml1) Group I 7.9–17.2 11.44 ± 2.681 6.455 0.000
Group II 3.1–9.1 6.02 ± 1.84
S. albumin (gm/dL) Group I 1.7–2.9 2.287 ± 0.318 3.078 0.005
Group II 2.1–3.2 2.693 ± 0.401
S. bil. (mg/dL) Group I 1.7–5.3 2.913 ± 0.969 0.026 0.979
Group II 1.1–7.1 2.900 ± 1.705
PT (s) Group I 14–22 16.867 ± 2.446 1.013 0.320
Group II 13–20 16.000 ± 2.236
S. creat. (mg/dL) Group I 0.5–1.2 0.993 ± 0.963 0.132 0.896
Group II 0.5–1.3 0.980 ± 0.254
BUN (mg/dL) Group I 13.0–49.0 23.533 ± 9.257 0.751 0.459
Group II 13.0 – 49.0 26.133 ± 9.709
TLC: total leukocytic count, bil.: bilirubin, PT: prothrombin time, creat.: creatinine, BUN: blood urea nitrogen.
Table 2 Comparison between both groups as regards ascitic
fluid examination.
Group Range Mean ± SD T test
t P-value
AF neutrophil count (cell/mm3)
Group I 275.0–918.0 535.533 ± 198.126 9.580 0.000
Group II 18.0–73.0 43.533 ± 17.513
AF total proteins (g/dL)
Group I 1.1–1z.8 1.447 ± 0.239 5.778 0.000
Group II 1.6–2.5 1.953 ± 0.242
AF albumin (g/dL)
Group I 0.5–1.30 0.847 ± 0.213 2.32 0.028
Group II 0.5–1.50 1.030 ± 0.285
AF LDH (mg/dL)
Group I 112.0–316.0 208.733 ± 52.340 3.287 0.003
Group II 95.0–274.0 147.733 ± 49.264
AF glucose (mg/dL)
Group I 99.0–159.0 129.733 ± 16.325 2.44 0.021
Group II 77.0–194.0 160.266 ± 45.626
AF: ascitic fluid, LDH: lactic dehydrogenase.
Role of ascitic fluid C3 in spontaneous bacterial peritonitis 833.1. Laboratory results
As shown in Table 1, comparing both groups as regards com-
plete blood count, liver and kidney function tests showed sig-
nificantly higher serum total leukocytic count and lower serum
albumin level in group I (P = 0.000 and 0.005, respectively),
while the rest of studied variables did not show any statistical
difference between both the study groups.
Ascitic fluid examination: Ascitic fluid neutrophil count and
LDH level was significantly higher in patients of group I com-
pared to those in group II (P-value 0.000 and 0.003, respec-
tively), while total proteins, albumin and glucose levels were
significantly lower in the patient of group I (P-value 0.000,
0.028 and 0.021, respectively) as shown in Table 2.3.2. Complement 3 levels in ascitic fluid
Comparing C3 levels between both groups: Ascitic fluid comple-
ment 3 levels were significantly lower in patients with SBP
(group I) than ascitic patients without SBP (group II) both
at baseline measurement and the follow-up readings as shown
in Table 3 and Fig. 1.
Comparing C3 levels during follow-up in each group: Table 4
shows a significant reduction in ascitic fluid complement 3 level
in group I, over the follow-up period of 3 months compared
with baseline reading on admission (P = 0.026), while this
was not observed in group II, patients who had no evidence
of SBP (P = 0.099).
Ascitic fluid complement 3 (C3) in different Child-Pugh
classes: When compared to Child-Pugh class ‘‘B’’ patients,
C3 levels were significantly lower in Child-Pugh class ‘‘C’’
patients in both the study groups independent of SBP
presence, Table 5.
Ascitic fluid C3 correlation with other AF variables: Ascitic
fluid C3 showed significant positive correlation with AF total
protein content (P = 0.000) while it showed significant nega-
tive correlation with the fluid neutrophil count and LDH level
(P= 0.000 and 0.011, respectively), as shown in Table 6.
4. Discussion
SBP is bacterial infection of the ascitic fluid without any intra-
abdominal source of infection [5]. We found that age and sex
have no effect on the incidence of SBP as there was no statis-
tically significant difference as regards both variables between
groups I and II. This was previously reported more than a dec-
ade ago by Puri et al. [6]. Advanced Child-Pugh class on the
other hand was significantly higher in group I patients (with
SBP) meaning that the severity of the liver disease is probably
an important risk factor for the development of SBP [3].
Etiology of liver cirrhosis was not significantly different be-
tween both our study groups, with HCV infection being the
most frequent cause of chronic liver disease, as shown before
by Abaza et al. [7]. The causative organism was isolated in
Table 5 AF complement 3 levels in Child-Pugh classes B and
C patients in groups I and II.
Child-Pugh class AF complement (C3) T-test
Range Mean ± SD t P-value
Group I
Class B 8.2–9.7 8.683 ± 0.704 3.872 0.002
Class C 5.8–8.6 6.602 ± 0.920
Group II
Class B 9.5–14.2 12.649 ± 1.513 4.074 0.001
Class C 8.7–10.7 9.758 ± 0.941
Table 3 Comparison between both groups as regards AF
complement 3 (C3) levels at baseline and follow-up readings.
Group AF complement (C3) (mg/dL) T-test
Range Mean ± SD t P-value
Baseline
Group I 5.8–9.7 7.157 ± 1.272 7.595 0.001
Group II 8.7–14.2 11.685 ± 1.928
1st follow-up
Group I 5.8–7.9 6.401 ± 0.653 9.639 0.001
Group II 8.5–14.4 11.498 ± 1.941
2nd follow-up
Group I 5.8–8.2 6.472 ± 0.726 8.617 0.001
Group II 7.6–14.1 11.363 ± 2.075
3rd follow-up
Group I 5.8–8.4 6.607 ± 0.880 8.079 0.001
Group II 7.9–14.0 11.320 ± 2.081
Table 6 AF complement 3 correlation with AF variables.
AF complement (C3)
r P-value
AF neutrophilic count 0.719 0.000
AF total protein 0.705 0.000
AF albumin 0.289 0.121
AF LDH 0.459 0.011
AF glucose 0.284 0.128
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while about a third of them represented culture negative neu-
trocytic ascites. E. coli and Klebsiela were the most frequently
detected organisms in AF cultures, while Gram-positive cocci
were detected in 20% of the cultures. This is in agreement with
Park et al., who found that Gram-negative organisms account
for more than 60% of the cases of SBP [8].
Comparing both groups as regards complete blood count,
liver and kidney function tests showed significantly higher ser-
um total leukocytic count and lower serum albumin level in
group I. Peripheral leukocytosis was repeatedly reported with
SBP as well as hypoalbuminemia as a marker of liver dysfunc-
tion [9]. The rest of liver and kidney functions were not signif-
icantly different between both the groups. Although S.
bilirubin and prothrombin times are both determining factors
in the Child-Pugh class of our patients, yet they were not sig-Table 4 Comparison of ascitic fluid C3 in each group across the st
SBP group
AF C3 (mg/dL), Mean ± SD P
Baseline 7.157 ± 1.272 0.026
1 month 6.401 ± 0.653
2 months 6.472 ± 0.726
3 months 6.607 ± 0.88
Figure 1 The persistently lower level ofnificantly affected in group I compared to group II. This might
be explained by the additive important role for albumin in
fighting infections in the ascitic fluid [10].
Ascitic fluid examination showed significantly higher neu-
trophil count as well as LDH level, while total proteins, albu-
min and glucose levels were significantly lower in patients of
group I compared with group II. High ascitic fluid neutrophil
count has been considered as the corner stone for the diagnosis
of SBP [11]. Consequently, the high LDH level in infected
ascitic fluid can be explained by either diffusion from the blood
or by the release from disintegrating AF neutrophils [12]. Onudy period.
Non-SBP group
AF C3 (mg/dL), Mean ± SD P
Baseline 11.685 ± 1.928 0.099
1 month 11.498 ± 1.941
2 months 11.363 ± 2.075
3 months 2.081
C3 in group I compared to group II.
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ascitic fluid have been identified as risk factors for SBP [13],
while ascitic fluid glucose could be consumed by bacteria dur-
ing uncontrolled infection [14].
In both groups the mean ascitic fluid C3 concentration was
significantly lower in patients of Child-Pugh class C than in
those of Child-Pugh class B, which can be explained by
changes in hepatic synthesis capacity [4]. The presumed mech-
anism for the decrease of C3 in the ascitic fluid is a combina-
tion of dilution, low hepatic synthesis, and greater
consumption of C3 due to an activation of the alternative com-
plement pathway [4]. Runyon reported that ascitic fluid pro-
tein concentration less than or equal to 1.0 g/dl, was
associated with a significantly higher risk for spontaneous peri-
tonitis. Our SBP patients had ascitic fluid protein of 1.1 g/dl;
which, though significantly lower than in patients without peri-
tonitis, were not to be considered high risk based on AF pro-
tein alone. This may highlight the need for an additional
marker for the risk of SBP. Complement 3 is an important pro-
tein which offers local defense against bacterial infections in
ascitic fluid [15]. This can explain its significantly reduced level
in group I patients (with the SBP) in our study groups. The
finding that ascitic fluid C3 level remained lower in group I
compared with group II over a follow-up period of 3 months,
supports our assumption that C3 reduction may be considered
as a factor in the occurrence of infection, rather than being
consumed during the infection. Moreover, there was further
significant reduction of the already low level of ascitic fluid
C3 in group I compared with same patients’ baseline reading.
This further reduction was not noticed in group II patients
who did not have SBP. This suggests the negative impact this
infection has on liver functions, leading to further deteriora-
tion, rather than the natural course of the cirrhosis. These find-
ings confirm that SBP is a recurrent problem and that
continuous antibiotic prophylaxis is a safe practice.
C3 level was significantly negatively correlated with AF
neutrophil count and LDH which confirms its value as a neg-
ative diagnostic marker of the infection. On the other hand, C3
was significantly positively correlated with ascitic fluid protein,
as shown in our results in baseline measurements, which ex-
plains the reduction in the ascitic fluid opsonic activity [16] pre-
disposing to the occurrence of SBP and confirming its
predicted role in the local defense against bacterial infection
of ascitic fluid. It can also be considered a potential predictive
marker of SBP, added to AF protein level, to enhance the
accuracy of the AF analysis.
In conclusion, our study confirms the role of ascitic fluid C3
in the local defense against bacterial infection of ascitic fluid in
cirrhotic patients. We also suggest that the reduced level of AF
complement 3 levels, in patients with SBP are more likely to be
a predisposing factor rather than consumption by alternate
complement activation due to the infection. The persistently
lower level of AF C3 and its further reduction over time in pa-
tients, who had one episode of SBP, should be further evalu-
ated to be used as a predictive and prognostic marker
increasing the sensitivity and specificity of ascitic fluid analysis.Disclaimer
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